艾塞利斯制药 EXEL
$69.57 +$0.86 (+1.25%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $69.57 0.00%
开盘$68.35
昨收$68.71
当日区间$68.01 – $70.32
成交量2.00M
市值$16.98B
市盈率（TTM）20.8
股息率–
EXEL 相关新闻
匹配 Exelixis 或代码 EXEL 的头条新闻，按最新排序。
- Truist Financial Maintains Exelixis(EXEL.US) With Hold Rating
- Analysts Offer Insights on NA Companies: Exelixis (EXEL) and Resolution Minerals Ltd. Sponsored ADR (RML)
- BofA Securities Maintains Exelixis(EXEL.US) With Sell Rating, Maintains Target Price $41
- Stifel Maintains Exelixis(EXEL.US) With Hold Rating
- William Blair Maintains Exelixis(EXEL.US) With Buy Rating
- Goldman Sachs Maintains Exelixis(EXEL.US) With Buy Rating, Maintains Target Price $64
- Truist Financial Maintains Exelixis(EXEL.US) With Hold Rating, Raises Target Price to $56 正面
- Goldman Sachs Maintains Exelixis(EXEL.US) With Buy Rating, Raises Target Price to $64 正面
- Analysts Offer Insights on Healthcare Companies: Caris Life Sciences, Inc. (CAI) and Exelixis (EXEL)
- H.C. Wainwright Maintains Exelixis(EXEL.US) With Buy Rating, Maintains Target Price $56
- Truist Financial Downgrades Exelixis(EXEL.US) to Hold Rating, Raises Target Price to $54 中性
- Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), Kiora Pharmaceuticals (KPRX) and MAIA Biotechnology, Inc. (MAIA)
- Stifel Maintains Exelixis(EXEL.US) With Hold Rating, Announces Target Price $47
- H.C. Wainwright Maintains Exelixis(EXEL.US) With Buy Rating, Raises Target Price to $56 正面
- A Quick Look at Today's Ratings for Exelixis(EXEL.US), With a Forecast Between $45 to $55
暂无评论——快来第一个聊聊 EXEL。
登录后参与讨论。